Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection

被引:160
作者
Peck, Angela J.
Englund, Janet A.
Kuypers, Jane
Guthrie, Katherine A.
Corey, Lawrence
Morrow, Rhoda
Hackman, Robert C.
Cent, Anne
Boeckh, Michael
机构
[1] Fred Hutchinson Canc Res Ctr, Program Infect Dis, Clin Res Div, Seattle, WA 98109 USA
[2] Univ Washington, Dept Med, Seattle, WA 98195 USA
[3] Childrens Hosp & Reg Med Ctr, Dept Pediat, Seattle, WA USA
[4] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
关键词
D O I
10.1182/blood-2006-12-060343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incidence of respiratory virus infection after hematopoietic cell transplantation (HCT) has probably been underestimated with conventional testing methods in symptomatic patients. This prospective study assessed viral infection episodes by testing weekly respiratory samples collected from HCT recipients, with and without symptoms reported by questionnaire, for 100 days after HCT. Samples were tested by culture and direct fluorescent antibody testing for respiratory syncytial virus (RSV), parainfluenza virus (PIV), and influenza A and B, and by quantitative reverse transcription-polymerase chain reaction for RSV, PIV, influenza A and B, and metapneumovirus (MPV). Of 122 patients, 30 (25%) had 32 infection episodes caused by RSV (5), PIV (17), MPV (6), influenza (3), RSV, or influenza (1). PIV, with a cumulative incidence estimate of 17.9%, was the only virus for which asymptomatic infection was detected. Lower virus copy number in patients with no or one symptom compared with 2 or more symptoms was found for all viruses in all patients (P < .001), with PIV infection having a similar virusspecific comparison (P = .004). Subcllnical infection with PIV may help explain why infection-control programs that emphasize symptoms are effective against RSV and influenza but often not against PIV.
引用
收藏
页码:1681 / 1688
页数:8
相关论文
共 49 条
[1]   Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV [J].
Adams, RH ;
Christenson, JC ;
Petersen, FB ;
Beatty, PG .
BONE MARROW TRANSPLANTATION, 1999, 24 (06) :661-664
[2]   Preemptive treatment of pediatric bone marrow transplant patients with asymptomatic respiratory syncytial virus infection with aerosolized ribavirin [J].
Adams, RH .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 :16S-18S
[3]   The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management [J].
Anaissie, EJ ;
Mahfouz, TH ;
Aslan, T ;
Pouli, A ;
Desikan, R ;
Fassas, A ;
Barlogie, B .
BLOOD, 2004, 103 (05) :1611-1617
[4]   Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants [J].
Boeckh, M ;
Berrey, MM ;
Bowden, RA ;
Crawford, SW ;
Balsley, J ;
Corey, L .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (03) :350-354
[5]  
Bowden Raleigh A., 1997, American Journal of Medicine, V102, P27, DOI 10.1016/S0002-9343(97)00007-7
[6]   Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease [J].
Cane, PA ;
van den Hoogen, BG ;
Chakrabarti, S ;
Fegan, CD ;
Osterhaus, ADME .
BONE MARROW TRANSPLANTATION, 2003, 31 (04) :309-310
[7]   Community respiratory virus infections in bone marrow transplant recipients: The MD Anderson Cancer Center experience [J].
Champlin, RE ;
Whimbey, E .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 :8S-10S
[8]   Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation [J].
Chien, JW ;
Martin, PJ ;
Gooley, TA ;
Flowers, ME ;
Heckbert, SR ;
Nichols, WG ;
Clark, JG .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (02) :208-214
[9]   Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population [J].
Cortez, KJ ;
Erdman, DD ;
Peret, TCT ;
Gill, VJ ;
Childs, R ;
Barrett, AJ ;
Bennett, JE .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (09) :1093-1097
[10]  
COUCH RB, 1990, ANTIVIR AGENTS VIR, P327